Matches 1 - 50 out of 357 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20100215643 ANTI-INFECTIVE FUNCTIONALIZED SURFACES AND METHODS OF MAKING SAME  
Devices are provided which are functionalized to include surface regions having anti-infective agents. Methods are provided for functionalizing various material surfaces to include active surface...
US20100035854 DRY POWDER FORMULATIONS  
A dry powder suitable for inhalation in a dry powder inhaler, the powder comprising a carrier, an active agent and at least 0.5% by weight of magnesium stearate, the powder being further...
US20080045489 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS  
Disclosed are novel cyclobutenedione Compounds 1 to 18 comprising a cyclobutenedione ring, a substituted phenyl ring, and a —CH(C2H5)-furan moiety. The phenyl ring and the —CH(C2H5)-furan moiety...
US20070202177 Antimicrobial Compositions and Methods for Locking Catheters  
Antimicrobial compositions for use in locking catheters and other devices are provided. In some embodiments, the composition includes at least one alcohol, at least one biocidal agent which is not...
US20050119160 Methods and reagents for the treatment of immunoinflammatory disorders  
The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted...
US20150266810 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION  
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and...
US20140336194 METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY  
The present invention provides the use of a neutral endopeptidase inhibitor, in the manufacture of a medicament for the treatment, amelioration and/or prevention of contrast-induced nephropathy....
US20140243326 Synergistic Insecticidal Mixtures  
The invention relates to insecticide mixtures comprising thiodicarb and at least one other known active ingredient from the category of chloronicotinyls, as well as the use of these mixtures to...
US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands  
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic...
US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture  
There is provided a method for preparing a pharmaceutical composition comprising compressible coated, taste-masked and/or controlled-release coated drug-containing particles, rapidly-dispersing...
US20110034513 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production  
Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof....
US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS  
This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
US20080317846 Pulsatile release histamine H2 antagonist dosage form  
A unit dosage form, such as a capsule or the like, for delivering drugs into the body in a circadian release fashion comprising one or more populations of drug-containing particles (beads,...
US20080031941 Gastric acid secretion inhibiting composition  
An oral pharmaceutical dosage form comprises pharmacologically effective amounts of an acid susceptible proton pump inhibitor or a salt thereof, an H2 receptor antagonist or a salt thereof and a...
US20060148869 Halogenated biaryl heterocyclic compounds and methods of making and using the same  
The present invention relates generally to the field of anti-infective anti-proliferative, anti-inflammatory, and prokinetic agents. More particularly, the invention relates to a family of...
US20050192345 Crystalline polymorphs of a CXC-chemokine receptor ligand  
The present invention relates to four distinct crystalline polymorphs of a monohydrate of Compound A having the following chemical structure: These four polymorphic forms, herein referred to as...
US20150140082 COMPOSITIONS AND METHODS FOR TREATMENT  
The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the...
US20120121724 FILM COMPRISING THERAPEUTIC AGENTS  
The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin, as well as...
US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance  
Methods of enabling or improving the ability of a hydrogel to swell in the stomach of an animal and/or increasing the amount of time said hydrogel remains swollen in the stomach are described...
US20070009484 Compositions and methods involving MDA-7 for the treatment of cancer  
The present invention concerns methods and compositions involving MDA-7 protein or an MDA-7-encoding nucleic acid in combination with either 1) a COX-2 selective inhibitor, such as celecoxib, 2)...
US20050112197 Stabilized oral pharmaceutical composition  
An orally deliverable pharmaceutical composition is provided comprising an aminosulfonyl-comprising drug, for example a selective cyclooxygenase-2 inhibitory drug such as celecoxib, and a solvent...
US20130303527 Fungicidal Active Substance Combinations Containing Trifloxystrobin  
What are described are novel active compound combinations comprising a known oxime ether derivative (trifloxystrobin) and imidacloprid, which combinations are highly suitable for controlling...
US20120142528 Methods Employing Fungicidal Active Substance Combinations Containing Trifloxystrobin  
What are described are novel active compound combinations comprising a known oxime ether derivative (trifloxystrobin) and imidacloprid, which combinations are highly suitable for controlling...
US20120108640 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS  
The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount,...
US20100196430 Controlled-released agricultural chemical formulation  
An object of the present invention is to provide an agricultural chemical formulation which is able to control release of an agricultural chemical active ingredient. This agricultural chemical...
US20100075914 METHODS FOR TREATING HERPES VIRUS INFECTIONS  
The present invention relates to methods for treating, killing, and/or inhibiting the growth of Herpes viruses in human subjects comprising topically administering to a human subject in need...
US20080306117 EP4 RECEPTOR ANTAGONISTS  
A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or(ii) an optionally...
US20080176938 Modulation of pathogenicity  
The present invention relates to the use of compounds of the general Formula (1): wherein in Formula (1), R is H, alkyl, cycloalkyl, aryl or heteroaryl;R1 is H, alkyl, cycloalkyl, aryl or...
US20070149526 Diuretic and diuretic-like compound analogs  
The present invention provides compounds that are effective in treating central nervous system disorders and maintaining normal brain function. Methods of making and using the compounds are also...
US20070041905 Method of treating depression using a TNF-alpha antibody  
The invention describes methods of treating depression comprising administering a TNFα antibody, such as a human TNFα antibody. The invention also provides a method for treating depression...
US20060194855 Method of treating migraines and pharmaceutical compositions  
A combination of a 5HT1B/1D agonist and a COX-2 selective inhibitor is useful in the treatment and or prevention of migraine.
US20050245582 High concentration topical insecticides containing pyrethroids  
A topical insecticide preparation is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The topical insecticide contains a...
US20120004225 BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE, AND TORSEMIDE ANALOGS, COMPOSITIONS AND METHODS OF USE  
The present invention provides bumetanide, furosemide, piretanide, azosemide, and torsemide analogs and compositions comprising such analogs. The present invention also provides pharmaceutical...
US20080234331 Synergistic Insecticidal Mixtures for the Treatment of Seed  
The invention relates to insecticidal mixtures containing, as active substances, at least two compounds from the series of the chloronicotinyl insecticides, and to the use of these mixtures for...
US20070280902 Method for treating eye disease or conditions affecting the posterior segment of the eye  
This invention relates to the use of prodrug for the manufacture of a medicament useful for treating an ocular disease affecting the posterior segment of the eye, in a subject in need thereof,...
US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs  
Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be...
US20150191420 ANTIBACTERIAL AGENTS  
Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R1)—; R1 is hydrogen and R2 is hydrogen, methyl, or fluorine; or R1...
US20130178446 METHOD FOR DECREASING SEBUM PRODUCTION  
The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these...
US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding  
The invention relates to a process for producing mouldings by injection moulding the steps in the process being a) melting and mixing of a (meth)acrylate copolymer composed of from 85 to 98% by...
US20070110685 Combination therapy for the treatment of immunoinflammatory disorders  
The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a non-steroidal immunophilin-dependent...
US20060120996 Vaccine immunotherapy for immune suppressed patients  
A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of a natural cytokine mixture (NCM), an effective amount of cyclophosphamide...
US20060014829 Methods for reducing hospitalizations related to heart failure  
The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a...
US20120234721 DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS  
The present invention provides compounds that are effective in treating central nervous system disorders and maintaining normal brain function. Methods of making and using the compounds are also...
US20120225118 COMPOSITIONS FOR DELIVERY OF INSOLUBLE AGENTS  
Compositions and methods of making the same for improving the bioavailability of a substantially water-insoluble pharmacologically active agent are described. The composition includes a...
US20110263601 METHODS OF TREATING ULCERATIVE COLITIS  
Methods are disclosed for treating ulcerative colitis and related diseases and disorders, which comprise inhibiting tryptophan hydroxylase (TPH) in patients in need thereof.
US20110224196 TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT  
This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from obstructive sleep apnea syndrome (OSAS). Treatment of OSAS is effected by...
US20100099682 ACETYLENE DERIVATIVES  
The invention provides compounds of formula (I) wherein R1 represents hydrogen or alkyl;R2 represents an unsubstituted or substituted heterocycle orR2 represents an unsubstituted or substituted...
US20060014828 Compositions and methods related to heart failure  
The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a...
US20130095176 CONTROLLED RELEASE DRUG DELIVERY COMPOSTION  
A controlled release delivery composition comprising: a housing adapted for oral administration; and a plurality of discrete vehicles assembled within the housing, each of the vehicles are not...
US20090149496 INHIBITORS OF THE TASK-1 AND TASK-3 ION CHANNEL  
The invention relates to the use of Kv1.5 inhibitors for the therapy or prophylaxis of respiratory disorders, sleep-related respiratory disorders, central and obstructive sleep apneas, upper...

Matches 1 - 50 out of 357 1 2 3 4 5 6 7 8 >